{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:29:49Z","timestamp":1788654589589,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SSIP scheme of Anand Pharmacy College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05344-3","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:32:27Z","timestamp":1777692747000},"page":"15791-15803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ufasome-based transdermal dual-vesicular gel of febuxostat and aceclofenac for sustained gout therapy: formulation optimization and pharmacodynamic evaluation"],"prefix":"10.1007","volume":"399","author":[{"given":"Khyati","family":"Parekh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-7703","authenticated-orcid":false,"given":"Vaishali","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-8936","authenticated-orcid":false,"given":"Devesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Sojitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"5344_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119470","volume":"10","author":"SH Abd El-Alim","year":"2025","unstructured":"Abd El-Alim SH, Salama A, Darwish AB (2025) Novel hybrid tri-polymer hyalurosomes: unlocking next-generation trans-tympanic therapeutics through multi-scale evaluations. International Journal of Pharmaceutics: X 10:100425. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119470","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"7","key":"5344_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18069","volume":"9","author":"F Abdulhafiz","year":"2023","unstructured":"Abdulhafiz F, Mohammed A, Farhan M, Reduan H, Hamzah Z, Kari ZA (2023) Evaluation of anti-hyperuricemic effects of Alocasia longiloba Miq . ( keladi candik ) extracts in potassium oxonate induced rat model. Heliyon 9(7):e18069. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18069","journal-title":"Heliyon"},{"key":"5344_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103726","volume":"76","author":"S Abedin","year":"2022","unstructured":"Abedin S, Karimi M, Rezaeilaal A, Jafariazar Z, Afshar M (2022) Formulation, in-vitro and ex-vivo evaluation of albendazole loaded ufasomal nanoformulation for topical delivery. J Drug Deliv Sci Technol 76:103726. https:\/\/doi.org\/10.1016\/j.jddst.2022.103726","journal-title":"J Drug Deliv Sci Technol"},{"key":"5344_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04659-x","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Fayez A, Attia H, El-Setouhy DA (2025a) Terpene-augmented novasomal carriers for trans-tympanic drug delivery: a comprehensive optimization and in vivo evaluation. Naunyn-Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04659-x","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5344_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107493","volume":"114","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Ibrahim MM, Balkhi B, Attia H, Aziz DE (2025) From bench to biology: unraveling the efficiency of novel brijosomes for trans-tympanic drug delivery. J Drug Deliv Sci Technol 114:107493. https:\/\/doi.org\/10.1016\/j.jddst.2025.107493","journal-title":"J Drug Deliv Sci Technol"},{"key":"5344_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1746918","volume":"16","author":"S Ahmed","year":"2026","unstructured":"Ahmed S, Saher O, Attia H, Fahmy AM, Adel IM (2026) Innovative dual-functional hybrid cationic PEGylated proniosomes as a smart nano-platform for boosted vaginal delivery: multi-level in-vitro, ex-vivo, microbiological, and in-vivo studies. Front Pharmacol 16:1746918. https:\/\/doi.org\/10.3389\/fphar.2025.1746918","journal-title":"Front Pharmacol"},{"issue":"3","key":"5344_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43094-020-00143-w","volume":"7","author":"S Bhattacharya","year":"2021","unstructured":"Bhattacharya S (2021) Preparation and characterizations of glyceryl oleate ufasomes of terbinafine hydrochloride: a novel approach to trigger Candida albicans fungal infection. Future J Pharm Sci 7(3):1\u201311. https:\/\/doi.org\/10.1186\/s43094-020-00143-w","journal-title":"Future J Pharm Sci"},{"key":"5344_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118998","volume":"268","author":"R Dhouibi","year":"2021","unstructured":"Dhouibi R, Affes H, Ben M, Moalla D, Marekchi R (2021) Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia); study of its reversibility and its maintenance. Life Sci 268:118998. https:\/\/doi.org\/10.1016\/j.lfs.2020.118998","journal-title":"Life Sci"},{"key":"5344_CR9","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-026-03342-5","author":"AM Fahmy","year":"2026","unstructured":"Fahmy AM, Saher O, Attia H, Farag MM, Ahmed S (2026) Harnessing novel tetra-synergistic bilosomes for effective otomycosis management: integrated in-vitro, microbiological and in-vivo studies. AAPS PharmSciTech. https:\/\/doi.org\/10.1208\/s12249-026-03342-5","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"5344_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Neogi T (2020) 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res 72(6):744\u2013760. https:\/\/doi.org\/10.1002\/acr.24180","journal-title":"Arthritis Care Res"},{"key":"5344_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-0348-7405-2","volume":"32","author":"M Grau","year":"1991","unstructured":"Grau M, Montero JL, Guasch J, Felipe A, Carrasco E, Julia S (1991) The pharmacological profile of aceclofenac, a new nonsteroidal antiinflammatory and analgesic drug. Agents Actions Suppl 32:125\u2013129. https:\/\/doi.org\/10.1007\/978-3-0348-7405-2","journal-title":"Agents Actions Suppl"},{"issue":"1","key":"5344_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics15010026","volume":"15","author":"SM Hashem","year":"2023","unstructured":"Hashem SM, Gad MK, Anwar HM, Saleh NM, Shamma RN, Elsherif NI (2023) Itraconazole-loaded ufasomes: evaluation, characterization, and anti-fungal activity against Candida albicans. Pharmaceutics 15(1):1\u201320. https:\/\/doi.org\/10.3390\/pharmaceutics15010026","journal-title":"Pharmaceutics"},{"key":"5344_CR13","unstructured":"Hickman RJ (2025) What to Know About a Uric Acid Test. https:\/\/www.verywellhealth.com\/uric-acid-test-4769739 Accessed 19 January 2026"},{"key":"5344_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/0091270005282634","volume":"46","author":"R Khosravan","year":"2006","unstructured":"Khosravan R, Grabowski BA, Mayer MD, Wu J, Joseph-ridge N, Vernillet L (2006) The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase. J Clin Pharmacol 46:88\u2013102. https:\/\/doi.org\/10.1177\/0091270005282634","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"5344_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/medicines5030103","volume":"5","author":"P Kumar","year":"2018","unstructured":"Kumar P, Singh SK, Handa V, Kathuria H (2018) Oleic acid nanovesicles of minoxidil for enhanced follicular delivery. Medicines 5(3):103. https:\/\/doi.org\/10.3390\/medicines5030103","journal-title":"Medicines"},{"key":"5344_CR16","unstructured":"Lademacher C, McDonald P, Ridge NJ, Taneja R (2009) Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents (Patent No. US 2009\/0042887 A1)"},{"issue":"10","key":"5344_CR17","first-page":"1332","volume":"12","author":"S Lakshmi","year":"2020","unstructured":"Lakshmi S, Manohar D, Mathan S, Dharan SS (2020) Ufasomes\u202f: a potential vesicular carrier system. J Pharm Sci Res 12(10):1332\u20131335","journal-title":"J Pharm Sci Res"},{"issue":"9","key":"5344_CR18","first-page":"4147","volume":"11","author":"PN Mallikarjun","year":"2022","unstructured":"Mallikarjun PN, Sowmya G, Kumar SM, Pooja K (2022) Preparation and in vitro evaluation of voriconazole loaded ufasomal suspension. Int J Biol Pharm Allied Sci 11(9):4147\u20134160","journal-title":"Int J Biol Pharm Allied Sci"},{"key":"5344_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/680580","volume":"2013","author":"R Mittal","year":"2013","unstructured":"Mittal R, Sharma A, Arora S (2013) Ufasomes mediated cutaneous delivery of dexamethasone\u202f: formulation and evaluation of anti-inflammatory activity by carrageenin-induced rat paw edema model. J Pharm 2013:680580. https:\/\/doi.org\/10.1155\/2013\/680580","journal-title":"J Pharm"},{"issue":"1","key":"5344_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37018\/sxaw2460","volume":"15","author":"S Naureen","year":"2021","unstructured":"Naureen S, Waseem R, Fatima J, Shah AA, Manzor H, Shaheen B (2021) Hepatotoxic effects of diclofenac and febuxostat combination on mice liver function tests after oral administration. J Fatima Jinnah Med Univ 15(1):1\u20136. https:\/\/doi.org\/10.37018\/sxaw2460","journal-title":"J Fatima Jinnah Med Univ"},{"issue":"13","key":"5344_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nano12132224","volume":"12","author":"C Oliveira","year":"2022","unstructured":"Oliveira C, Ferreira CJO, Sousa M, Paris JL, Gaspar R, Silva BFB, Teixeira JA, Ferreira-santos P, Botelho CM (2022) A versatile nanocarrier \u2014 cubosomes , characterization , and applications. Nanomaterials 12(13):2224. https:\/\/doi.org\/10.3390\/nano12132224","journal-title":"Nanomaterials"},{"key":"5344_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100100","volume":"11","author":"T Patil","year":"2021","unstructured":"Patil T, Soni A, Acharya S (2021) A brief review on in vivo models for gouty arthritis. Metab Open 11:100100. https:\/\/doi.org\/10.1016\/j.metop.2021.100100","journal-title":"Metab Open"},{"issue":"7","key":"5344_CR23","first-page":"544","volume":"8","author":"JA Prajapati","year":"2019","unstructured":"Prajapati JA, Humbal BR, Sadariya KA, Shailesh B, Thaker AM (2019) Determination of in-vivo anti-inflammatory potential of Cinnamomum zeylanicum oil in female wistar rats. The Pharma Innovation Journal 8(7):544\u2013547","journal-title":"The Pharma Innovation Journal"},{"issue":"5","key":"5344_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","volume":"8","author":"G Ragab","year":"2017","unstructured":"Ragab G, Elshahaly M, Bardin T (2017) Gout: an old disease in new perspective \u2013 a review. J Adv Res 8(5):495\u2013511. https:\/\/doi.org\/10.1016\/j.jare.2017.04.008","journal-title":"J Adv Res"},{"issue":"5","key":"5344_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12272-013-0073-y","volume":"36","author":"Y Rhee","year":"2013","unstructured":"Rhee Y, Nguyen T, Park E, Chi SC (2013) Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac. Arch Pharm Res 36(5):602\u2013607. https:\/\/doi.org\/10.1007\/s12272-013-0073-y","journal-title":"Arch Pharm Res"},{"issue":"6","key":"5344_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3109\/10837450.2015.1048553","volume":"21","author":"AH Salama","year":"2016","unstructured":"Salama AH, Aburahma MH (2016) Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging. Pharm Dev Technol 21(6):706\u2013715. https:\/\/doi.org\/10.3109\/10837450.2015.1048553","journal-title":"Pharm Dev Technol"},{"issue":"15","key":"5344_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158319","volume":"22","author":"M Sguizzato","year":"2021","unstructured":"Sguizzato M, Esposito E, Cortesi R (2021) Lipid-based nanosystems as a tool to overcome skin barrier. Int J Mol Sci 22(15):8319. https:\/\/doi.org\/10.3390\/ijms22158319","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5344_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2174\/1872210515666210415114118","volume":"16","author":"N Sharma","year":"2022","unstructured":"Sharma N, Kumar S, Joshi G, Chodhary D (2022) Formulation and characterization of febuxostat loaded nanostructured lipid carriers (NLCs) - gel for topical treatment of gout. Recent Pat Nanotechnol 16(3):250\u2013258. https:\/\/doi.org\/10.2174\/1872210515666210415114118","journal-title":"Recent Pat Nanotechnol"},{"key":"5344_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jddst.2017.04.020","volume":"39","author":"S Singh","year":"2017","unstructured":"Singh S, Parashar P, Kanoujia J, Singh I, Saha S, Saraf SA (2017) Transdermal potential and anti-gout efficacy of febuxostat from niosomal gel. J Drug Deliv Sci Technol 39:348\u2013361. https:\/\/doi.org\/10.1016\/j.jddst.2017.04.020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"5344_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115952","volume":"9","author":"J Somagoni","year":"2014","unstructured":"Somagoni J, Boakye CHA, Godugu C, Patel AR, Faria HAM, Zucolotto V, Singh M (2014) Nanomiemgel - a novel drug delivery system for topical application - in vitro and in vivo evaluation. PLoS One 9(12):e115952. https:\/\/doi.org\/10.1371\/journal.pone.0115952","journal-title":"PLoS One"},{"issue":"7","key":"5344_CR31","first-page":"1128","volume":"12","author":"V Sreenivasulu","year":"2023","unstructured":"Sreenivasulu V, Sampath Kumar K, Vamsi Krishna T, Maheswara Reddy D, B M (2023) Formulation and in-vitro characterization of verapamil hydrochloride ufasomes. Eur. Chem. Bull. 12(7):1128\u20131139","journal-title":"Eur. Chem. Bull."},{"key":"5344_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03250-0","author":"MA Tawfik","year":"2025","unstructured":"Tawfik MA, Ahmed S, El-Dahmy RM, Aziz DE (2025) Oleic acid enriched leciplexes as novel mucoadhesive cationic nanocarriers of agomelatine for glaucoma treatment. AAPS PharmSciTech. https:\/\/doi.org\/10.1208\/s12249-025-03250-0","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"5344_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/S13346-015-0219-1","volume":"5","author":"S Tiwari","year":"2015","unstructured":"Tiwari S, Dwivedi H, Kymonil KM, Saraf SA (2015) Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach. Drug Deliv Transl Res 5(3):219\u2013230. https:\/\/doi.org\/10.1007\/S13346-015-0219-1","journal-title":"Drug Deliv Transl Res"},{"key":"5344_CR34","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.molliq.2017.08.002","volume":"242","author":"AM Vohra","year":"2017","unstructured":"Vohra AM, Patel CV, Kumar P, Thakkar HP (2017) Development of dual drug loaded solid self microemulsifying drug delivery system: exploring interfacial interactions using qbd coupled risk based approach. J Mol Liq 242:1156\u20131168. https:\/\/doi.org\/10.1016\/j.molliq.2017.08.002","journal-title":"J Mol Liq"},{"key":"5344_CR35","unstructured":"Walker R (2012) Clinical pharmacy and therapeutics, 5th edn. Elsevier publication, pp 848\u2013858"},{"issue":"6","key":"5344_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/BF02207932","volume":"14","author":"DE Ward","year":"1995","unstructured":"Ward DE, Veys EM, Bowdler JM, Roma J (1995) Comparison of aceclofenac with diclofenac in the treatment of ostroarthritis. Clin Rheumatol 14(6):656\u2013662. https:\/\/doi.org\/10.1007\/BF02207932","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5344_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/RHU.0b013e318204aab4","volume":"17","author":"A Whelton","year":"2011","unstructured":"Whelton A, Macdonald PA, Zhao \u00deL, Hunt \u00deB, Gunawardhana L (2011) Renal function in gout: long-term treatment effects of febuxostat. J Clin Rheumatol 17(1):7\u201313. https:\/\/doi.org\/10.1097\/RHU.0b013e318204aab4","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"5344_CR38","first-page":"860","volume":"35","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Peng X, Ling G (2017) An update on the animal models in hyperuricaemia research. Clin Exp Rheumatol 35(5):860\u2013864","journal-title":"Clin Exp Rheumatol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05344-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:04:13Z","timestamp":1784775853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05344-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5344"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05344-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An in vivo study was performed according to experimental protocol, approved by Institutional Animal Ethical Committee (Reference number: APC\/2024-IAEC\/2420).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"One of the authors, Devesh Kapoor, is an editorial board member.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI models such as Grammarly and QuillBot have been used for the refinement of English language in this manuscript.","order":3,"name":"Ethics","label":"Declaration of AI utilization","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical trial number is not applicable.","order":4,"name":"Ethics","label":"Clinical trials","group":{"name":"EthicsHeading","label":"Declarations"}}]}}